-
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
Equity healthcare
Overview ( as on 04/11/25 )
NAV
₹40.51
Last change
₹-0.24 -0.01%
Fund Size (AUM)
6226.82 Cr
Performance
20.57% (5Y)
Fund Details
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
as of 04/11/25
AUM
6226.82 Cr
Expense Ratio
1.87 %
Benchmark
BSE Healthcare TR INR
ISIN
INF109KC1GE9
Fund Manager
Dharmesh Kakkad
Exit Load
1.0% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth | 5.36% | 26.67% | 20.57% |
| BSE Healthcare TR INR | 1.4% | 23.01% | 18.25% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.58% |
Dr Reddy's Laboratories Ltd |
9.1% |
Divi's Laboratories Ltd |
8.75% |
Aurobindo Pharma Ltd |
8.25% |
Cipla Ltd |
6.92% |
Lupin Ltd |
5.43% |
Alkem Laboratories Ltd |
4.05% |
Biocon Ltd |
3.11% |
Gland Pharma Ltd |
2.97% |
Mankind Pharma Ltd |
2.95% |
Sector Allocation
Healthcare |
97.7% |
Basic Materials |
1.18% |
Financial |
1.12% |
Asset Allocation
-
98%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
20.57% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
19.9% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
19.73% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R
Equity healthcare-
Returns
-
19.73% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
17.75% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
17.75% (5Y)
-
